Healthcare provider profile · identity verified

Hani Issa, M.D.

Geriatric Medicine · PENNY FARMS, FL · NPI 1619144045

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	469	87
Amlodipine Besylate	Amlodipine Besylate	291	55
Losartan Potassium	Losartan Potassium	270	64
Furosemide	Furosemide	224	40
Lisinopril	Lisinopril	177	40
Atorvastatin Calcium	Atorvastatin Calcium	176	44
Eliquis	Apixaban	169	32
Tamsulosin Hcl	Tamsulosin Hcl	155	35
Omeprazole	Omeprazole	139	33
Metoprolol Succinate	Metoprolol Succinate	132	33
Carvedilol	Carvedilol	103	17
Donepezil Hcl	Donepezil Hcl	103	19
Sertraline Hcl	Sertraline Hcl	103	25
Metformin Hcl	Metformin Hcl	99	20
Potassium Chloride	Potassium Chloride	96	19
Prednisone	Prednisone	90	46
Pantoprazole Sodium	Pantoprazole Sodium	87	17
Nystatin	Nystatin	84	21
Metoprolol Tartrate	Metoprolol Tartrate	81	13
Clopidogrel	Clopidogrel Bisulfate	80	14
Memantine Hcl	Memantine Hcl	79	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	78	18
Ibuprofen	Ibuprofen	69	33
Cephalexin	Cephalexin	64	31
Finasteride	Finasteride	61	13
Fluoxetine Hcl	Fluoxetine Hcl	61	16
Montelukast Sodium	Montelukast Sodium	59	15
Pravastatin Sodium	Pravastatin Sodium	59	14
Duloxetine Hcl	Duloxetine Hcl	57	16
Ropinirole Hcl	Ropinirole Hcl	57	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	56	45
Lorazepam	Lorazepam	56	18
Doxycycline Monohydrate	Doxycycline Monohydrate	55	34
Simvastatin	Simvastatin	55	15
Trazodone Hcl	Trazodone Hcl	53	14
Meloxicam	Meloxicam	52	13
Rosuvastatin Calcium	Rosuvastatin Calcium	52	11
Tramadol Hcl	Tramadol Hcl	52	15
Methylprednisolone	Methylprednisolone	51	34
Famotidine	Famotidine	48	suppressed
Gabapentin	Gabapentin	48	18
Hydrochlorothiazide	Hydrochlorothiazide	48	suppressed
Allopurinol	Allopurinol	43	12
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Lamotrigine	Lamotrigine	39	suppressed
Alendronate Sodium	Alendronate Sodium	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	20
Olanzapine	Olanzapine	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Latanoprost	Latanoprost	31	suppressed
Midodrine Hcl	Midodrine Hcl	31	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Divalproex Sodium	Divalproex Sodium	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Bumetanide	Bumetanide	28	suppressed
Albuterol Sulfate	Albuterol Sulfate	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Metronidazole	Metronidazole	24	suppressed
Repaglinide	Repaglinide	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	11
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Torsemide	Torsemide	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Anastrozole	Anastrozole	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Novolin R Flexpen	Insulin Regular, Human	17	suppressed
Nystop	Nystatin	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Valsartan	Valsartan	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Azithromycin	Azithromycin	14	11
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Mirabegron Er	Mirabegron	12	suppressed
Nyamyc	Nystatin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Temazepam	Temazepam	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Novolin R	Insulin Regular, Human	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error